2021 ICD-10-CM Code P04.16

Newborn affected by maternal use of amphetamines

Version 2021

Billable Code

Valid for Submission

P04.16 is a billable diagnosis code used to specify a medical diagnosis of newborn affected by maternal use of amphetamines. The code P04.16 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.

ICD-10:	P04.16
Short Description:	Newborn affected by maternal use of amphetamines
Long Description:	Newborn affected by maternal use of amphetamines

Code Classification

Certain conditions originating in the perinatal period (P00–P96)
- Newborn affected by maternal factors and by complications of pregnancy, labor, and delivery (P00-P04)
  - NB aff by noxious substnc transmitd via plcnta or brst milk (P04)

Index to Diseases and Injuries

The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code P04.16 are found in the index:

- Newborn (infant) (liveborn) (singleton) - Z38.2
- - affected by
  - - maternal (complication of) (use of)
    - - amphetamines - P04.16

Replacement Code

P0416 replaces the following previously assigned ICD-10 code(s):

P04.1 - Newborn affected by oth maternal medication
P04.1 - Newborn affected by other maternal medication

Code History

FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019

Previous Code: P04.15

Related Codes

Next Code: P04.17